Trilobio, developer of whole lab automation solutions for advancing biology research, has introduced the first version of its comprehensive robotics, lab equipment and software platform at the Society for Laboratory Automation and Screening conference, SLAS2025, alongside pilot customer data, demonstrating the platform’s abilities in advancing research workflows...
Aston Institute for Membrane Excellence (AIME) has received a £500,000 grant from the Wolfson Foundation to purchase an ultrafast confocal spinning disc microscope. This instrument will accelerate AIME research, led by Professor Roslyn Bill, into treatments for dementia and other forms of cognitive decline. An ultrafast spinning disc confocal microscope enables faster, higher-resolution images of biological processes than is currently possible at AIME...
The European Molecular Biology Laboratory (EMBL) and the European Laboratory for Learning and Intelligent Systems (ELLIS) have agreed upon a Memorandum of Understanding (MoU) to promote interdisciplinary training and develop innovative projects that address pressing challenges in human and planetary health. EMBL Director General Edith Heard and ELLIS President Bernhard Schölkopf signed the agreement at an event on “Shaping Europe’s AI Leadership” in Brussels on 14 January 2025...
Leading science and innovation campus, Discovery Park, in Sandwich, Kent has launched applications for the fourth cohort of its immersive business growth competition, ‘Discovery Spark’. Supported by Capital Enterprise Network and Cancer Research UK (CRUK), Discovery Park’s latest Discovery Spark programme will have an oncology theme. It invites cancer tech start-ups looking to accelerate their business to apply...
Azenta, Inc. has announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale sample storage in support of the preservation of internationally significant sample collections. This new system is in addition to the seven Azenta BioArc™ Flex™ automated sample store systems already in place at the facility. UK Biocentre will utilize the new BioArc Ultra™ to deliver on critical research projects including the United Kingdom’s largest health research program
Scientists and engineers will collaborate to develop and verify platform workflows utilizing the broad offering of automation-enabled assays from the Life Science business of Merck KGaA, Darmstadt, Germany. Together, the custom workstation and automation-enabled assays will deliver increased consistency and higher throughput by reducing manual processing and repetitive tasks with a user-friendly robotic system...
Cormica, a global leader in life sciences testing and consulting, has completed the acquisition of Zwisler Laboratorium, a premier provider of laboratory services headquartered in Reichenau, Germany. This landmark acquisition marks Cormica’s first entry into the German market, a key milestone in its strategy to expand its European footprint. The move underlines Cormica’s commitment to becoming a leading operator in high-growth European markets, with plans to explore additional opportunities for expansion in Germany...
Labomatic Instruments AG and KNAUER Wissenschaftliche Geräte GmbH are pleased to announce a strategic cooperation aimed at combining their complementary strengths to offer a larger portfolio to their respective customer bases. Customers in the liquid chromatography segment in particular are likely to benefit from the complementary expertise, especially in terms of flow rate and pressure ranges...
Revvity, Inc.has announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow for newborn sequencing research and strengthens Element’s momentum towards regulatory approval of the benchtop AVITI™ sequencing system...
Pioneering use of artificial intelligence (AI) could cut the time it takes to bring life-saving treatments to patients. This represents just one example of innovation being championed by the UK's seven new regulatory science powerhouses. Innovate UK – the UK’s innovation agency, in partnership with the Medicines and Healthcare products Regulatory Agency (MHRA), Office for Life Sciences, and the Medical Research Council have announced seven Centres of Excellence for Regulatory Science and Innovation...
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis. The pilot program is based on Illumina's upcoming proteomics assay, Illumina Protein Prep™, powered by SOMAmer® technology, a next-generation sequencing (NGS) based solution that will help scale access to proteomic insights...
Leaders from across the region will meet to discuss the advancements in lab technology and the overarching industry, which has seen numerous developments over the past couple of years. With the conference setting its eyes on the evolution of the lab it will address 9 important and varying themes that encompass the breadth of this ever-growing field in Basel, May 27-28...
London Lab Live 2025 is set to debut on 14–15 May 2025 at ExCeL London, bringing together professionals from across the lab sector to inspire collaboration and innovation. Representing industries such as chemical and material science, FMCG, food and beverage, agriculture, pharma, biotech, medical, real estate, academia, and beyond, the event promises to be the UK’s most dynamic gathering for the lab community...
Shimadzu Corporation, a pioneer in scientific instrumentation and technology, is proud to announce the celebration of its 150th anniversary. Founded in Kyoto on March 31, 1875, Shimadzu has been at the forefront of innovation and excellence in science and technology for over a century and a half. To commemorate this significant milestone, Shimadzu Corporation has launched a special website today, inviting everyone to join in the celebration...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink® Explore Platform to support the world’s largest human proteomics study of its kind. UKB-PPP aims to analyze more than 5,400 proteins from 600,000 samples to fuel the discovery of new protein biomarkers that can be used to predict, diagnose and treat diseases...
Leica Biosystems, a global leader in anatomic and digital pathology solutions; and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, have announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.
Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market. This cutting-edge benchtop instrument allows scientists to easily quantify antibodies, AAVs, and other proteins directly from crude samples in as little as one minute, providing critical data on the spot, enhancing efficiency and accuracy in life science research and bioprocessing...
Pioneer Group has announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commercialising intellectual property in the healthcare and sustainability sectors. Through the collaboration, biotech startups based at Pioneer sites across the UK and Ireland, including its new landmark life sciences location at Victoria House in London in partnership with Oxford Properties, will receive access to training, events, technical support, bespoke equipment, and consumables from Thermo Fisher...
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, and reduce the industry’s reliance on animal testing. HUB is a pioneer in the field of organoids...
ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications. Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF...
AN influential cross-party Lords Committee has written to the Government to raise concerns about its preparedness for future pandemics, describing the current situation as “troubling”. In a letter to Pat McFadden, Chancellor of the Duchy of Lancaster, Baroness Brown of Cambridge, chair of the House of Lords Science and Technology Committee, said experts had raised “troubling concerns about (the UK’s) capacity to manufacture vaccines for future biological threats”...
Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February 26–28, 2025, at the Fort Lauderdale Marriott Harbor Beach Resort, the event will bring together leading experts in research and technology to explore the transformative role of AI and science-aware lab informatics in accelerating research, discovery, diagnostics, manufacturing, and business operations in the life sciences.
Trilobio, developer of whole lab automation solutions for advancing biology research, has introduced the first version of its comprehensive robotics, lab equipment and software platform at the Society for Laboratory Automation and Screening conference, SLAS2025, alongside pilot customer data, demonstrating the platform’s abilities in advancing research workflows...
Aston Institute for Membrane Excellence (AIME) has received a £500,000 grant from the Wolfson Foundation to purchase an ultrafast confocal spinning disc microscope. This instrument will accelerate AIME research, led by Professor Roslyn Bill, into treatments for dementia and other forms of cognitive decline. An ultrafast spinning disc confocal microscope enables faster, higher-resolution images of biological processes than is currently possible at AIME...
The European Molecular Biology Laboratory (EMBL) and the European Laboratory for Learning and Intelligent Systems (ELLIS) have agreed upon a Memorandum of Understanding (MoU) to promote interdisciplinary training and develop innovative projects that address pressing challenges in human and planetary health. EMBL Director General Edith Heard and ELLIS President Bernhard Schölkopf signed the agreement at an event on “Shaping Europe’s AI Leadership” in Brussels on 14 January 2025...
Leading science and innovation campus, Discovery Park, in Sandwich, Kent has launched applications for the fourth cohort of its immersive business growth competition, ‘Discovery Spark’. Supported by Capital Enterprise Network and Cancer Research UK (CRUK), Discovery Park’s latest Discovery Spark programme will have an oncology theme. It invites cancer tech start-ups looking to accelerate their business to apply...
Azenta, Inc. has announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale sample storage in support of the preservation of internationally significant sample collections. This new system is in addition to the seven Azenta BioArc™ Flex™ automated sample store systems already in place at the facility. UK Biocentre will utilize the new BioArc Ultra™ to deliver on critical research projects including the United Kingdom’s largest health research program
Scientists and engineers will collaborate to develop and verify platform workflows utilizing the broad offering of automation-enabled assays from the Life Science business of Merck KGaA, Darmstadt, Germany. Together, the custom workstation and automation-enabled assays will deliver increased consistency and higher throughput by reducing manual processing and repetitive tasks with a user-friendly robotic system...
Cormica, a global leader in life sciences testing and consulting, has completed the acquisition of Zwisler Laboratorium, a premier provider of laboratory services headquartered in Reichenau, Germany. This landmark acquisition marks Cormica’s first entry into the German market, a key milestone in its strategy to expand its European footprint. The move underlines Cormica’s commitment to becoming a leading operator in high-growth European markets, with plans to explore additional opportunities for expansion in Germany...
Labomatic Instruments AG and KNAUER Wissenschaftliche Geräte GmbH are pleased to announce a strategic cooperation aimed at combining their complementary strengths to offer a larger portfolio to their respective customer bases. Customers in the liquid chromatography segment in particular are likely to benefit from the complementary expertise, especially in terms of flow rate and pressure ranges...
Revvity, Inc.has announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow for newborn sequencing research and strengthens Element’s momentum towards regulatory approval of the benchtop AVITI™ sequencing system...
Pioneering use of artificial intelligence (AI) could cut the time it takes to bring life-saving treatments to patients. This represents just one example of innovation being championed by the UK's seven new regulatory science powerhouses. Innovate UK – the UK’s innovation agency, in partnership with the Medicines and Healthcare products Regulatory Agency (MHRA), Office for Life Sciences, and the Medical Research Council have announced seven Centres of Excellence for Regulatory Science and Innovation...
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis. The pilot program is based on Illumina's upcoming proteomics assay, Illumina Protein Prep™, powered by SOMAmer® technology, a next-generation sequencing (NGS) based solution that will help scale access to proteomic insights...
Leaders from across the region will meet to discuss the advancements in lab technology and the overarching industry, which has seen numerous developments over the past couple of years. With the conference setting its eyes on the evolution of the lab it will address 9 important and varying themes that encompass the breadth of this ever-growing field in Basel, May 27-28...
London Lab Live 2025 is set to debut on 14–15 May 2025 at ExCeL London, bringing together professionals from across the lab sector to inspire collaboration and innovation. Representing industries such as chemical and material science, FMCG, food and beverage, agriculture, pharma, biotech, medical, real estate, academia, and beyond, the event promises to be the UK’s most dynamic gathering for the lab community...
Shimadzu Corporation, a pioneer in scientific instrumentation and technology, is proud to announce the celebration of its 150th anniversary. Founded in Kyoto on March 31, 1875, Shimadzu has been at the forefront of innovation and excellence in science and technology for over a century and a half. To commemorate this significant milestone, Shimadzu Corporation has launched a special website today, inviting everyone to join in the celebration...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink® Explore Platform to support the world’s largest human proteomics study of its kind. UKB-PPP aims to analyze more than 5,400 proteins from 600,000 samples to fuel the discovery of new protein biomarkers that can be used to predict, diagnose and treat diseases...
Leica Biosystems, a global leader in anatomic and digital pathology solutions; and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, have announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.
Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market. This cutting-edge benchtop instrument allows scientists to easily quantify antibodies, AAVs, and other proteins directly from crude samples in as little as one minute, providing critical data on the spot, enhancing efficiency and accuracy in life science research and bioprocessing...
Pioneer Group has announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commercialising intellectual property in the healthcare and sustainability sectors. Through the collaboration, biotech startups based at Pioneer sites across the UK and Ireland, including its new landmark life sciences location at Victoria House in London in partnership with Oxford Properties, will receive access to training, events, technical support, bespoke equipment, and consumables from Thermo Fisher...
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, and reduce the industry’s reliance on animal testing. HUB is a pioneer in the field of organoids...
ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications. Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF...
AN influential cross-party Lords Committee has written to the Government to raise concerns about its preparedness for future pandemics, describing the current situation as “troubling”. In a letter to Pat McFadden, Chancellor of the Duchy of Lancaster, Baroness Brown of Cambridge, chair of the House of Lords Science and Technology Committee, said experts had raised “troubling concerns about (the UK’s) capacity to manufacture vaccines for future biological threats”...
Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February 26–28, 2025, at the Fort Lauderdale Marriott Harbor Beach Resort, the event will bring together leading experts in research and technology to explore the transformative role of AI and science-aware lab informatics in accelerating research, discovery, diagnostics, manufacturing, and business operations in the life sciences.